Annexon, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ANNX | ATTO | B9A.F | AGMB | ODTX | ACRS | |
|---|---|---|---|---|---|---|
| Market cap | 820.88M | 712.16M | 2.45B | 337.35M | 937.14M | 570.34M |
| P/E (TTM) | — | — | 250.7 | — | — | — |
| Forward P/E | -4.0 | -6.6 | — | -3.4 | -4.5 | -5.1 |
| Price/book | 4.1 | -0.5 | 1.2 | 2.7 | 2.5 | 4.1 |
| Dividend yield | — | — | 0.68% | — | — | — |
| 1-year change | +43.38% | −30.27% | +13.08% | −53.24% | +18.76% | +62.11% |
| Today | +3.34% | +2.16% | −0.29% | 0.00% | −9.60% | −1.60% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All ANNX news ›Annexon, Inc. (ANNX) Discusses Vonaprument Phase III ARCHER II Trial in Geographic Atrophy Transcript
Annexon, Inc. (ANNX) Discusses Vonaprument Phase III ARCHER II Trial in Geographic Atrophy November 3, 2026 11:00 AM EST Douglas Love - CEO, President & DirectorRoger Goldberg - Co-founder & Chief Medical AdvisorLloyd Clark - Senior Vice…
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
The Manila Times In the aggregate, the six new non-executive employees received options to purchase 1,270,000 shares of Annexon common stock. The options carry a ten-year term and an exercise price per share equa
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- manilatimes.net2
- globenewswire.com1
- stocktitan.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.